These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effects of a short course of eszopiclone on continuous positive airway pressure adherence: a randomized trial. Lettieri CJ; Shah AA; Holley AB; Kelly WF; Chang AS; Roop SA; Ann Intern Med; 2009 Nov; 151(10):696-702. PubMed ID: 19920270 [TBL] [Abstract][Full Text] [Related]
4. Clinical and polysomnographic predictors of short-term continuous positive airway pressure compliance. Collen J; Lettieri C; Kelly W; Roop S Chest; 2009 Mar; 135(3):704-709. PubMed ID: 19017888 [TBL] [Abstract][Full Text] [Related]
5. A pilot study evaluating acute use of eszopiclone in patients with mild to moderate obstructive sleep apnea syndrome. Rosenberg R; Roach JM; Scharf M; Amato DA Sleep Med; 2007 Aug; 8(5):464-70. PubMed ID: 17512799 [TBL] [Abstract][Full Text] [Related]
6. Zolpidem and Eszopiclone Pre-medication for PSG: Effects on Staging, Titration, and Adherence. Holley AB; Londeree WA; Sheikh KL; Andrada TF; Powell TA; Khramtsov A; Hostler JM Mil Med; 2018 Jul; 183(7-8):e251-e256. PubMed ID: 29961838 [TBL] [Abstract][Full Text] [Related]
7. A polysomnography study of eszopiclone in elderly patients with insomnia. McCall WV; Erman M; Krystal AD; Rosenberg R; Scharf M; Zammit GK; Wessel T Curr Med Res Opin; 2006 Sep; 22(9):1633-42. PubMed ID: 16968566 [TBL] [Abstract][Full Text] [Related]
8. Eszopiclone for the treatment of posttraumatic stress disorder and associated insomnia: a randomized, double-blind, placebo-controlled trial. Pollack MH; Hoge EA; Worthington JJ; Moshier SJ; Wechsler RS; Brandes M; Simon NM J Clin Psychiatry; 2011 Jul; 72(7):892-7. PubMed ID: 21367352 [TBL] [Abstract][Full Text] [Related]
9. A randomized placebo-controlled polysomnographic study of eszopiclone in Japanese patients with primary insomnia. Uchimura N; Kamijo A; Kuwahara H; Uchiyama M; Shimizu T; Chiba S; Inoue Y Sleep Med; 2012 Dec; 13(10):1247-53. PubMed ID: 23063301 [TBL] [Abstract][Full Text] [Related]
10. Impact of zaleplon on continuous positive airway pressure therapy compliance. Park JG; Olson EJ; Morgenthaler TI J Clin Sleep Med; 2013 May; 9(5):439-44. PubMed ID: 23674934 [TBL] [Abstract][Full Text] [Related]
11. The impact of eszopiclone on sleep and cognition in patients with schizophrenia and insomnia: a double-blind, randomized, placebo-controlled trial. Tek C; Palmese LB; Krystal AD; Srihari VH; DeGeorge PC; Reutenauer EL; Guloksuz S Schizophr Res; 2014 Dec; 160(1-3):180-5. PubMed ID: 25454802 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of treatment of insomnia in migraineurs with eszopiclone (Lunesta®) and its effect on total sleep time, headache frequency, and daytime functioning: A randomized, double-blind, placebo-controlled, parallel-group, pilot study. Spierings EL; McAllister PJ; Bilchik TR Cranio; 2015 Apr; 33(2):115-21. PubMed ID: 25323219 [TBL] [Abstract][Full Text] [Related]
13. An oral hypnotic medication does not improve continuous positive airway pressure compliance in men with obstructive sleep apnea. Bradshaw DA; Ruff GA; Murphy DP Chest; 2006 Nov; 130(5):1369-76. PubMed ID: 17099012 [TBL] [Abstract][Full Text] [Related]
14. Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitations. Walsh JK; Krystal AD; Amato DA; Rubens R; Caron J; Wessel TC; Schaefer K; Roach J; Wallenstein G; Roth T Sleep; 2007 Aug; 30(8):959-68. PubMed ID: 17702264 [TBL] [Abstract][Full Text] [Related]
15. A 12-week, randomized, double-blind, placebo-controlled study evaluating the effect of eszopiclone 2 mg on sleep/wake function in older adults with primary and comorbid insomnia. Ancoli-Israel S; Krystal AD; McCall WV; Schaefer K; Wilson A; Claus R; Rubens R; Roth T Sleep; 2010 Feb; 33(2):225-34. PubMed ID: 20175406 [TBL] [Abstract][Full Text] [Related]
16. The Combination of Supplemental Oxygen and a Hypnotic Markedly Improves Obstructive Sleep Apnea in Patients with a Mild to Moderate Upper Airway Collapsibility. Edwards BA; Sands SA; Owens RL; Eckert DJ; Landry S; White DP; Malhotra A; Wellman A Sleep; 2016 Nov; 39(11):1973-1983. PubMed ID: 27634790 [TBL] [Abstract][Full Text] [Related]
17. A randomized, double-blind, placebo-controlled trial of eszopiclone for the treatment of insomnia in patients with chronic low back pain. Goforth HW; Preud'homme XA; Krystal AD Sleep; 2014 Jun; 37(6):1053-60. PubMed ID: 24882900 [TBL] [Abstract][Full Text] [Related]
18. Eszopiclone in patients with insomnia during perimenopause and early postmenopause: a randomized controlled trial. Soares CN; Joffe H; Rubens R; Caron J; Roth T; Cohen L Obstet Gynecol; 2006 Dec; 108(6):1402-10. PubMed ID: 17138773 [TBL] [Abstract][Full Text] [Related]
19. Eszopiclone for insomnia associated with attention-deficit/hyperactivity disorder. Sangal RB; Blumer JL; Lankford DA; Grinnell TA; Huang H Pediatrics; 2014 Oct; 134(4):e1095-103. PubMed ID: 25266438 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of eszopiclone across 6-weeks of treatment for primary insomnia. Zammit GK; McNabb LJ; Caron J; Amato DA; Roth T Curr Med Res Opin; 2004 Dec; 20(12):1979-91. PubMed ID: 15701215 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]